PGIMER Starts Clinical Trial of Sepsivac For COVID-19 Treatment

PGIMER's Clinical Trial of Sepsivac For Covid-19 Treatment The Post
Graduate Institute of Medical Education and Research in Chandigarh
announced that they have started the clinical trial of Sepsivac on
asymptomatic coronavirus patients. Amid the rising number of Covid-19
patients in India, on Wednesday, the clinical trial of Sepsivac on
asymptomatic coronavirus patients has started […]

The post PGIMER Starts Clinical Trial of Sepsivac For COVID-19
Treatment appeared first on BioTecNika .

https://www.biotecnika.org/2020/04/pgimers-clinical-trial-of-sepsivac-covid-19-vaccine-trials-at-pgimer/

Biotech News

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment